PTI-428

Proteostasis Therapeutics' Abrupt Turn-Around on Share Offering
CP Wire
Tue, 03/20/18 - 11:20 pm
Proteostasis Therapeutics
stock offering
PTI-428
cystic fibrosis
clinical trials